Federation des caisses Desjardins du Quebec’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26K Hold
856
﹤0.01% 2038
2025
Q4
$24.7K Sell
856
-250
-23% -$3.27K ﹤0.01% 2008
2025
Q3
$7.97K Hold
1,106
﹤0.01% 2328
2025
Q2
$11K Sell
1,106
-626
-36% -$6.61K ﹤0.01% 2006
2025
Q1
$16.4K Hold
1,732
﹤0.01% 1795
2024
Q4
$23.9K Sell
1,732
-326
-16% -$5.71K ﹤0.01% 1622
2024
Q3
$31.3K Buy
2,058
+126
+7% +$623 ﹤0.01% 1530
2024
Q2
$9.22K Hold
1,932
﹤0.01% 1831
2024
Q1
$13.1K Hold
1,932
﹤0.01% 1758
2023
Q4
$9.45K Hold
1,932
﹤0.01% 1766
2023
Q3
$6.61K Hold
1,932
﹤0.01% 1849
2023
Q2
$9.23K Hold
1,932
﹤0.01% 1781
2023
Q1
$8.15K Hold
1,932
﹤0.01% 1812
2022
Q4
$7.46K Hold
1,932
﹤0.01% 1944
2022
Q3
$11.6K Sell
1,932
-3,374
-64% -$17.3K ﹤0.01% 1876
2022
Q2
$18.5K Hold
5,306
﹤0.01% 1784
2022
Q1
$18.2K Hold
5,306
﹤0.01% 1852
2021
Q4
$15.5K Hold
5,306
﹤0.01% 1912
2021
Q3
$21.3K Hold
5,306
﹤0.01% 1837
2021
Q2
$27.2K Sell
5,306
-27,994
-84% -$119K ﹤0.01% 1773
2021
Q1
$156K Buy
33,300
+24,000
+258% +$138K ﹤0.01% 1193
2020
Q4
$31.9K Sell
9,300
-10,450
-53% -$45.3K ﹤0.01% 1624
2020
Q3
$104K Buy
19,750
+6,300
+47% +$36.7K ﹤0.01% 1049
2020
Q2
$61.9K Buy
+13,450
New +$58.6K ﹤0.01% 1161

Other funds holding CAPR

Federation des caisses Desjardins du Quebec's CAPR Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Capricor Therapeutics (CAPR) position steady in Q1 2026 at 856 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

Federation des caisses Desjardins du Quebec first reported a position in CAPR in Q2 2020 and has held it in 24 quarters since. The position peaked at $156K in Q1 2021. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 856 shares of Capricor Therapeutics worth $26K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Capricor Therapeutics share count unchanged in Q1 2026.
  • Capricor Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2038 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Capricor Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Federation des caisses Desjardins du Quebec's Capricor Therapeutics position peaked at $156K in Q1 2021.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.